Publications

Publications

Filter Results: (22) Arrow Down

Show Results For

Page 1 of 22 Results →
  • September 17, 2020
  • Article

Protecting Vulnerable Older Patients during the Pandemic

By: Umar Ikram, Susanna Gallani, Jose F. Figueroa and Thomas W. Feeley
Older people (70 years and older) with multiple chronic conditions have the highest risk of being hospitalized and dying from COVID-19. The recent COVID-19 pandemic has highlighted how a strong primary care system can play an important role in protecting this group of... View Details
Keywords: COVID-19; High-risk Patients; Primary Care; Health Pandemics; Health Care and Treatment; Innovation and Invention; Demographics; Age
Related
  • 10 Aug 2015
  • Research & Ideas

New Medical Devices Get To Patients Too Slowly

device was defined using the FDA's standard as one that "supports or sustains human life or is of substantial importance in preventing impairment of human health or presents a potential, unreasonable risk of illness or injury.") The View Details
Keywords: by Michael Blanding; Health; Technology
  • 01 Mar 2017
  • Research & Ideas

A Good Thing Happens When Doctors Start Talking to Their Patients

transportation and clinical visits, but their patients end up having 45 percent lower hospitalization rates,” Kaplan says. Kaiser Permanente Colorado implemented a similar program with a high-risk elderly... View Details
Keywords: by Michael Blanding; Health
  • January 2024
  • Article

A Cost Model for a Low Threshold Clinic Treating Opioid Use Disorder

By: Sarah E. Wakeman, Elizabeth Powell, Syed Shehab, Grace Herman, Laura Kehoe and Robert S. Kaplan
The US fee-for-service payment system under-reimburses clinics offering access to comprehensive treatments for opioid use disorder (OUD). The funding shortfall limits a clinic’s ability to expand and improve access, especially for socially marginalized patients with... View Details
Keywords: Health Care and Treatment; Cost; Equality and Inequality; Health Industry
Related
  • 03 Apr 2020
  • News

How Hospitals Are Using AI to Battle Covid-19

  • September 2024
  • Case

Myeloma Investment Fund

By: Kyle Myers and Scott Sawaya
This case explores a critical decision facing the Myeloma Investment Fund (MIF) as it evaluates two investment opportunities aimed at accelerating a cure for multiple myeloma.

The MIF, a venture philanthropy fund, must choose between two distinct paths. One... View Details
Keywords: Venture Philanthropy; Biomedical Research; Investing For Impact; Innovation ＆ Entrepreneurship; Venture Capital; Science-Based Business; Philanthropy and Charitable Giving; Decision Making; Health Care and Treatment; Biotechnology Industry; Pharmaceutical Industry
Related
  • November 2024
  • Article

The Health Costs of Cost Sharing

By: Amitabh Chandra, Evan Flack and Ziad Obermeyer
What happens when patients suddenly stop their medications? We study the health consequences of drug interruptions caused by large, abrupt, and arbitrary changes in price. Medicare’s prescription drug benefit as-if-randomly assigns 65-year-olds a drug budget as a... View Details
Keywords: Outcome or Result; Health Care and Treatment; Budgets and Budgeting; Cost
Related
  • Article

Navy Medicine Introduces Value-Based Health Care

By: Alee Hernandez, Robert S. Kaplan, Mary L. Witkowski, C. Forrest Faison III and Michael E. Porter
In 2016 the newly appointed surgeon general of the Navy launched a value-based health care pilot project at Naval Hospital Jacksonville to explore whether multidisciplinary care teams (known as integrated practice units, or IPUs) and measurement of outcomes could... View Details
Keywords: Military Health System; Health Care and Treatment; Cost Management; Projects
Related
  • January 2018
  • Article

The Central and Unacknowledged Role of the U.S. Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials

By: Aaron V. Kaplan and Ariel D. Stern
The introduction of new medical devices has transformed cardiovascular care in recent decades. Devices, such as heart valves, pacemakers, stents, ventricular assist devices, and implantable defibrillators, have prolonged and improved the quality of life for millions of... View Details
Keywords: Health Testing and Trials; Business and Government Relations; Governing Rules, Regulations, and Reforms; Information Publishing; Medical Devices and Supplies Industry; United States
Related
  • 29 Jun 2015
  • HBS Case

Consumer-centered Health Care Depends on Accessible Medical Records

to target high-risk patient segments with advice about exercise, nutrition, and other programs in an effort to minimize medical visits. The problem: insurers' claims data is not as current as hospitals'... View Details
Keywords: by Dina Gerdeman; Health; Technology
  • January 2023
  • Case

Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery

By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Related
  • Web

Blavatnik Fellowship in Life Science Entrepreneurship - Health Care

make biologics more accessible to patients worldwide. Sanso was created to commercialize the microporous water technology out of Jarad Mason's lab at Harvard, a novel solution to dramatically increase the oxygen capacity of most aqueous... View Details
  • 14 Jan 2019
  • Op-Ed

These 4 CEOs Created a New Standard of Leadership

Clinic’s historic mission of putting patients first. He prioritized Mayo’s focus on the most complex diseases patients faced, using its research to develop new treatments for many diseases. He reorganized... View Details
Keywords: by Bill George; Health; Banking; Food & Beverage; Consumer Products
  • 18 Jul 2024
  • Blog Post

Harvard Business School Announces Its 2024-2025 Blavatnik Fellows

immune system-driven dendritic cell therapy to combat cancer, new molecular technologies for the delivery of transdermal formulations, a lipid-targeting drug to treat cancer and neurodegenerative disorders, and AI-driven medical companions to help View Details
  • 12 Jul 2004
  • Research & Ideas

Michael Porter’s Prescription For the High Cost of Health Care

to Choice. Under positive-sum competition, all restrictions to choice at the disease or treatment level would disappear, including network restrictions and approvals of referrals. Reasonable co-pays and large deductibles combined with medical savings accounts would let... View Details
Keywords: by Michael E. Porter; Health
  • 31 Jan 2017
  • First Look

First Look at New Research: January 31, 2017

reports involving high-risk cardiovascular devices by linking regulatory review times for all 106 new, high-risk cardiovascular devices approved from 2000 to 2009 to subsequent adverse event reports. Reports... View Details
Keywords: Carmen Nobel
  • 19 Jan 2016
  • First Look

January 19, 2016

Markets By: Baker, Malcolm Abstract—The link between measures of risk and return within the equity market has been very weak over the past 47 years: in the United States, returns on high-risk stocks have cumulatively fallen short of the... View Details
Keywords: Sean Silverthorne
  • 01 Mar 2007
  • News

Daniel Vasella

Vasella Illustration by Dennis Balogh Twenty years ago a young doctor with a hankering for business experience gave up his clinical practice in Bern, Switzerland, and moved to East Hanover, New Jersey, to try his hand at drug sales with the Swiss conglomerate Sandoz.... View Details
Keywords: Roger Thompson; multinational pharmaceutical company; prescription drugs; vaccines; Medicare; generics business; Health, Social Assistance
  • 03 Jul 2012
  • Research & Ideas

HBS Faculty on Supreme Court Health Care Ruling

the average expenses of the sick enrolled in state high-risk pools ranged from $8,000 to $24,000. Even the top 10 percent of taxpayers, with incomes over $110,000, could barely afford these sums. Sick people are currently insured because... View Details
Keywords: Re: Multiple Faculty; Health
  • 14 Nov 2017
  • First Look

New Research and Ideas: November 14, 2017

expensive. How can health care organizations change this? One key is to prioritize quality improvement over cost cutting. By harnessing IT to help design better clinical practices, it’s possible to achieve better patient outcomes and... View Details
Keywords: Carmen Nobel